Communiqués

03/09 SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company AQ
13/08 SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results AQ
06/08 SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET AQ
30/07 SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering AQ
16/07 SRX Global Regains Full Compliance with NYSE American Listing Standards AQ
14/07 SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026 AQ
10/07 SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders AQ
09/07 SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding AQ
08/07 SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1) AQ
08/07 SRX Global Declares One-Time Cash Dividend AQ
02/07 SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines AQ
24/06 SRX Global Announces Share Consolidation AQ
23/06 SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences AQ
18/06 SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets AQ
29/05 SRx Health Solutions Invests in Uber Technologies, Inc. and Provides Shareholders with Portfolio Update AQ
21/05 SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) AQ
18/05 SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII AQ
15/05 SRx Health Solutions Announces Board Approval to Dividend 75% of Profits from Investment in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies AQ
14/05 SRx Health Solutions Announces Fiscal Second Quarter 2026 Results for Quarter Ended March 31, 2026 AQ
13/05 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital and SPV with Investments in SpaceX and Other Artificial Intelligence and Space Companies AQ
22/04 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital AQ
17/04 SRx Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson AQ
16/04 SRx Health Solutions Acquires Shares of Compass Inc. and Increases Investment in Opendoor Technologies Inc. AQ
07/04 SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine AQ
25/03 SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge AQ
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT